Eiko LifeSciences Limited (BOM:540204)

Eiko LifeSciences Revenue

In the fiscal year ending March 31, 2026, Eiko LifeSciences had annual revenue of 536.79M INR with 42.52% growth. Eiko LifeSciences had revenue of 184.69M in the quarter ending March 31, 2026, with 63.88% growth.

• Revenue: 536.79M
• Revenue Growth: +42.52%
• P/S Ratio: 1.51
• Revenue / Employee: 76.68M
• Employees: 7
• Market Cap: 808.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	536.79M	160.16M	42.52%
Mar 31, 2025	376.64M	97.35M	34.85%
Mar 31, 2024	279.29M	96.08M	52.44%
Mar 31, 2023	183.21M	-70.91M	-27.90%
Mar 31, 2022	254.12M	134.21M	111.93%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error